Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
New treatments for cocaine dependence: A focused review
Laurent Karila
, David Gorelick
,
Aviv Weinstein
, Florence Noble
, Amine Benyamina
, Sarah Coscas
, Lisa Blecha
, William Lowenstein
, Jean Luc Martinot
, Michel Reynaud
, Jean Pierre Lépine
Research output
:
Contribution to journal
›
Review article
›
peer-review
160
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New treatments for cocaine dependence: A focused review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cocaine Dependence
100%
Focused Review
100%
Clinical Trials
25%
Preclinical Development
25%
Cocaine Vaccine
25%
Cocaine
12%
Pharmacological Treatment
12%
Human Studies
12%
Patient Demographics
12%
Statistical Methods
12%
MEDLINE
12%
Embase
12%
North America
12%
Methylphenidate
12%
Recent Advances
12%
Ondansetron
12%
N-acetylcysteine
12%
Dopamine Agonist
12%
Topiramate
12%
English Language
12%
South America
12%
Neurobiology
12%
Pharmacological Approaches
12%
Pharmacological Agents
12%
Serotonergic System
12%
Pharmacotherapy
12%
PsycINFO
12%
Drug-related Problems
12%
Modafinil
12%
Socio-economic Impact
12%
Legal Implications
12%
Vigabatrin
12%
Tiagabine
12%
Disulfiram
12%
Regulatory Approval
12%
Neuronal Mechanisms
12%
Agonist Replacement
12%
Aripiprazole
12%
Socio-legal
12%
GABA Agents
12%
Early Phase Clinical Trials
12%
Baclofen
12%
Drug Scenes
12%
Inpatient Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cocaine Dependence
100%
Clinical Trial
37%
Human Study
12%
Pharmacotherapy
12%
Zofran
12%
Dopamine Receptor Stimulating Agent
12%
Methylphenidate
12%
Topiramate
12%
Vigabatrin
12%
Tiagabine
12%
4 Aminobutyric Acid
12%
Disulfiram
12%
Aripiprazole
12%
Modafinil
12%
Baclofen
12%
N-Acetylcysteine
12%
Neuroscience
Vigabatrin
12%
Serotonergic System
12%
Tiagabine
12%
Baclofen
12%